glp-1 receptor agonists effects on cardiovascular risk reduction of in Heart Failure Patients Cardiovascular Effects and Tolerability of
Description
Studies in mice and humans showed that GLP-1 liraglutide acts directly and indirectly in LDL and VLDL catabolism, increases lipoprotein lipase gene expression responsible for TAG hydrolysis, and reduces apolipoprotein B48, diacylglycerol O -acyltransferase 1, and microsomal transfer protein gene expression, all of which are involved in chylomicron synthesis [77, 78]
Initial injectable therapy in type 2 diabetes: key considerations when choosing between glucagon-like peptide 1 receptor agonists and insulin
2013;304:E1314E1320
Novo Nordisks blockbuster molecule, semaglutide, was launched for Type 2 diabetes (T2D) in 2018 as Ozempic
What purity standard should researchers require for retatrutide
doi: 10.1152/ajpendo.00419.2016 28 HartterESvobodaTLudvikBSchullerMLellBKuenburgEet al
